About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Initiates Arbitration Against Mylan
January 7, 2016
Click here to read more
Post navigation
Previous Post
Phosphagenics’ PHN Trial Completes Enrolment and Dosing
Next Post
Phosphagenics Reports Positive Resuls for Weaner Pig Efficiency Trial
Related Posts
AGM Chairman and CEO Addresses
May 31, 2017
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
May 16, 2024
Phosphagenics Still Awaits SIAC Arbitration Update
June 8, 2018